Expression of fibrosis-related genes in human renal allografts with interstitial fibrosis and tubular atrophy

Journal of Nephrology

Volumn 26, Issue 6, 2013, Pages 1179-1187

  Nogare, Aline L ^a   Dalpiaz, Tiago ^a   Pedroso, José A ^b   Montenegro, Rosângela M ^b   Pegas, Karla L ^b   Veronese, Francisco V ^a,b   Gonçalves, Luiz F ^a,b   Manfro, Roberto C ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Gene expression; Graft fibrosis; Interstitial fibrosis; Renal transplantation; Tubular atrophy

Indexed keywords

CALCINEURIN INHIBITOR; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; KIDNEY INJURY MOLECULE 1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ACUTE CALCINEURIN INHIBITOR NEPHROTOXICITY; ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; ATROPHY; CREATININE BLOOD LEVEL; CTGF GENE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TUBULE DISORDER; KIDNEY TUBULE NECROSIS; KIM 1 GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROTOXICITY; PATHOGENESIS; PROTEIN URINE LEVEL; TGF BETA GENE; TUBULAR ATROPHY; ALLOGRAFT; BIOPSY; FIBROSIS; GENETICS; GRAFT REJECTION; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; AGED; ALLOGRAFTS; ATROPHY; BIOPSY; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FIBROSIS; GENE EXPRESSION; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, VIRUS; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84889673740     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000274     Document Type: Article

References (47)

1. Cecka JM. The OPTN/UNOS renal transplant registry. In: Cecka JM, Terasaki PI, eds. Clinical transplant. Los Angeles, CA: UCLA Tissue Typing Laboratory; 2005;1-16.
2. Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010;363(15):1451-1462.
3. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450-462.
4. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753-760.
5. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Toxicol. 2008;48:463-493.
6. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69(2):213-217.
7. Kapoor M, Liu S, Huh K, Parapuram S, Kennedy L, Leask A. Connective tissue growth factor promoter activity in normal and wounded skin. Fibrogenesis Tissue Repair. 2008; 1(1):3.
8. Mannon RB. Immune monitoring and biomarkers to predict chronic allograft dysfunction. Kidney Int Suppl. 2010; 119:59-65.
9. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant. 2009;9(10):2312-2323.
10. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant. 2007;7(12): 2712-2722.
11. Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal. 2009;3(2):89-94.
12. Moussad EE, Brigstock DR. Connective tissue growth factor: what's in a name? Mol Genet Metab. 2000;71(1-2): 276-292.
13. Gore-Hyer E, Shegogue D, Markiewicz M, et al. TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol. 2002;283(4): F707-F716.
14. Qi W, Chen X, Twigg S, et al. The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming growth factor-beta1. Nephrology (Carlton). 2007;12(3):267-274.
15. Cheng O, Thuillier R, Sampson E, et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant. 2006;6(10):2292-2306.
16. Aihara K, Ikeda Y, Yagi S, Akaike M,Matsumoto T. Transforming growth factor-β1 as a common target molecule for development of cardiovascular diseases, renal insufficiency and metabolic syndrome. Cardiol Res Pract. 2011; 2011:175381.
17. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 2003;116(Pt 2):217-224.
18. Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol. 2002;282(5): F933-F942.
19. Surazynski A, Miltyk W, Prokop I, Palka J. Prolidasedependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts. Eur J Pharmacol. 2010;649(1-3):115-119.
20. Fukuda N, Tahira Y, Matsuda H, Matsumoto K. Transforming growth factor-β as a treatment target in renal diseases. J Nephrol. 2009;22(6):708-715.
21. Lawrence DA. Transforming growth factor-beta: an overview. Kidney Int Suppl. 1995;49:S19-S23.
22. Basile DP. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens. 1999;8(1): 21-30.
23. Sharma VK, Bologa RM, Xu GP, et al. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int. 1996;49(5):1297-1303.
24. Pribylova-Hribova P, Kotsch K, Lodererova A, et al. TGFbeta1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int. 2006;69(10):1872-1879.
25. Mas V, Maluf D, Archer K, et al. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation. 2007;83(4):448-457.
26. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212(2): 209-217.
27. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7): 4135-4142.
28. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem. 2002;277(42):39739-39748.
29. Degauque N, Mariat C, Kenny J, et al. Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins. Transplantation. 2007;84(1)(Suppl):S12-S16.
30. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008;118(5):1657-1668.
31. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004;286(3):552-563.
32. Zhou Y, Vaidya VS, Brown RP, et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008;101(1):159-170.
33. Huo W, Zhang K, Nie Z, Li Q, Jin F. Kidney injury molecule-1 (KIM-1): a novel kidney specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev. 2010;24(3):143-146.
34. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237-244.
35. Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 2008;73(5):608-614.
36. Schröppel B, Krüger B, Walsh L, et al. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol. 2010;21(3):536-542.
37. van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. 2007;84(12):1625-1630.
38. Nauta FL, Bakker SJ, van Oeveren W, et al. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis. 2011;57(5):733-743.
39. Scherer A, Gwinner W, Mengel M, et al. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrol Dial Transplant. 2009;24(8): 2567-2575.
40. Vitalone MJ, O'Connell PJ, Wavamunno M, Fung CL, Chapman JR, Nankivell BJ. Transcriptome changes of chronic tubulointerstitial damage in early kidney transplantation. Transplantation. 2010;89(5):537-547.
41. Naesens M, Khatri P, Li L, et al. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int. 2011;80(12): 1364-1376.
42. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349(2):125-138.
43. Maluf DG, Mas VR, Archer KJ, et al. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med. 2008;14(5-6): 276-285.
44. Akalin E, O'Connell PJ. Genomics of chronic allograft injury. Kidney Int Suppl. 2010;119(119):S33-S37.
45. Scian MJ, Maluf DG, David KG, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011;10(10):2110-2122.
46. Moore J, McKnight AJ, Simmonds MJ, et al. Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA. 2010;303(13):1282-1287.
47. Krüger B, Schröppel B. Genetic variations and transplant outcomes. Nephron Clin Pract. 2011;118(1):49-54.